Manufacturing · Maryland, United States · 339 Employees
View Company Info for Free
$559M
Total Funding Amount
$110M
Most Recent Funding Amount
10
Number of Funding Rounds
MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics f or the treatment of cancer. The combination of MacroGenics' technology platforms and protein engineering has allowed the Company to generate product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.Read more
Let us give you the heads up on whether it's a good time to reach out
Click to see if MacroGenics had a recent Job posting/layoffs
Earning: See what the market has to say on MacroGenics recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at MacroGenics
Check if MacroGenics has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when MacroGenics launches new products
Website visits: Recent activity has been detected on your website
MacroGenics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once MacroGenics has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if MacroGenics is spiking on competitors!
Recommended Actions
Find VP level buyers at MacroGenics
Find 2 more new buyers
Analyze insights from companies similar to MacroGenics and make strategic comparisons based on performance, financial data, growth and unique benchmarks.
More similar companies
Gather financial insights about MacroGenics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
View MacroGenics’s full employee growth data
Percentage of growth
1st year Mask
2nd year Mask
A closer look at the technologies used by MacroGenics
MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer. The combination of MacroGenics' technology platforms and protein engineering has allowed the Company to generate product candidates and enter into several strategic collaborat... Read More
